市場調査レポート

商品コード

1085804

抗炎症薬の世界市場：薬剤タイプ、用途、投与経路、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Anti-inflammatory Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月14日 | 発行: Coherent Market Insights

| ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 700,920円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,557,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

関節炎などの急性・慢性疾患の増加が、抗炎症薬市場の成長を促進すると期待されます。しかし、抗炎症薬の副作用が、市場成長を妨げると予測されます。

当レポートでは、世界の抗炎症薬市場について調査分析し、市場概要、市場力学、動向、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

ヒートマップ分析
市場シェア分析
- Pfizer, Inc.
- GlaxoSmithKline plc
- Johnson &Johnson Services Inc.
- Merck &Company, Inc.
- Novartis AG
- Amgen, Inc.
- AstraZeneca plc
- Eli Lily and Company
- AbbVie Inc.
- F. Hoffmann-La Roche AG
- Bristol Myers Squibb Company
- Biogen Inc.
- Sun Pharmaceutical Industries Ltd
- Mylan, Inc.
- Aurobindo Pharma Limited
- Dr. Reddy's Laboratories
- アナリストの見解

第11章セクション

Product Code: CMI4327

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Market Dynamics

Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults and in rural areas in the U.S., 1 in 3 adults has arthritis.

However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye's syndrome, which is potentially fatal.

Key features of the study:

This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy's Laboratories among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.

Detailed Segmentation:

Global Anti-inflammatory Drugs Market, By Drug Type:
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
- Anti-inflammatory Biologics
- Corticosteroids
Global Anti-inflammatory Drugs Market, By Application:
- Arthritis
- Chronic Obstructive Pulmonary Disease (COPD)
- Multiple Sclerosis
- Inflammatory Bowel Disease (IBD)
- Gout
- Others
Global Anti-inflammatory Drugs Market, By Route of Administration:
- Oral
- Topical
- Injection
- Inhalation
Global Anti-inflammatory Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anti-inflammatory Drugs Market, By Region:
- North America
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Drug Type:
  - Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  - Anti-inflammatory Biologics
  - Corticosteroids
  - By Application:
  - Arthritis
  - Chronic Obstructive Pulmonary Disease (COPD)
  - Multiple Sclerosis
  - Inflammatory Bowel Disease (IBD)
  - Gout
  - Others
  - By Route of Administration:
  - Oral
  - Topical
  - Injection
  - Inhalation
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Pfizer, Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc.
- Merck & Company, Inc.
- Novartis AG
- Amgen, Inc.
- AstraZeneca plc
- Eli Lily and Company
- AbbVie Inc.
- F. Hoffmann-La Roche AG
- Bristol Myers Squibb Company
- Biogen Inc.
- Sun Pharmaceutical Industries Ltd
- Mylan, Inc.
- Aurobindo Pharma Limited
- Dr. Reddy's Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Market Scenario
Impact of COVID-19 Market on the Anti-inflammatory Drugs Products

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Anti-inflammatory Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Inflammatory Bowel Disease (IBD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Gout
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson Services Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Company, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amgen, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lily and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biogen Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views

11. Section

References
Research Methodology
About us and Sales Contact

抗炎症薬の世界市場：薬剤タイプ、用途、投与経路、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Anti-inflammatory Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界の抗炎症薬市場：コロナウイルス（COVID-19）パンデミックの影響

第5章世界の抗炎症薬市場：薬剤タイプ別（2017年～2028年）

第6章世界の抗炎症薬市場：用途別（2017年～2028年）

第7章世界の抗炎症薬市場：投与経路別（2017年～2028年）

第8章世界の抗炎症薬市場：流通チャネル別（2017年～2028年）

第9章世界の抗炎症薬市場：地域別（2017年～2028年）

第10章競合情勢

第11章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2017 - 2028, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2017 - 2028, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2017 - 2028, (US$ Mn)

10. Competitive Landscape

11. Section

抗炎症薬の世界市場：薬剤タイプ、用途、投与経路、流通チャネル、地域別 - 規模、シェア、見通し、機会分析（2022年～2028年）

Anti-inflammatory Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場の展望

第3章 市場力学・規制・動向分析

第4章 世界の抗炎症薬市場：コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の抗炎症薬市場：薬剤タイプ別（2017年～2028年）

第6章 世界の抗炎症薬市場：用途別（2017年～2028年）

第7章 世界の抗炎症薬市場：投与経路別（2017年～2028年）

第8章 世界の抗炎症薬市場：流通チャネル別（2017年～2028年）

第9章 世界の抗炎症薬市場：地域別（2017年～2028年）

第10章 競合情勢

第11章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2017 - 2028, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2017 - 2028, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2017 - 2028, (US$ Mn)

10. Competitive Landscape

11. Section

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学・規制・動向分析

第4章世界の抗炎症薬市場：コロナウイルス（COVID-19）パンデミックの影響

第5章世界の抗炎症薬市場：薬剤タイプ別（2017年～2028年）

第6章世界の抗炎症薬市場：用途別（2017年～2028年）

第7章世界の抗炎症薬市場：投与経路別（2017年～2028年）

第8章世界の抗炎症薬市場：流通チャネル別（2017年～2028年）

第9章世界の抗炎症薬市場：地域別（2017年～2028年）

第10章競合情勢

第11章セクション